Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray).
Grimaldi AE, De Giglio L, Haggiag S, Bianco A, Cortese A, Crisafulli SG, Monteleone F, Marfia G, Prosperini L, Galgani S, Mirabella M, Centonze D, Pozzilli C, Castelli L. Grimaldi AE, et al. Among authors: crisafulli sg. PLoS One. 2019 Jul 30;14(7):e0219670. doi: 10.1371/journal.pone.0219670. eCollection 2019. PLoS One. 2019. PMID: 31361750 Free PMC article.
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation.
Belvisi D, Canevelli M, Baione V, Buscarinu MC, Pellicciari G, Fantozzi R, Creta A, Cecchi G, Cola G, Nicoletti CG, Cortese A, De Giglio L, Tartaglia M, Crisafulli SG, Bruno G, Ferraro E, Marfia GA, Centonze D, Salvetti M, Conte A. Belvisi D, et al. Among authors: crisafulli sg. Mult Scler. 2021 Oct;27(12):1939-1947. doi: 10.1177/1352458520987541. Epub 2021 Feb 10. Mult Scler. 2021. PMID: 33565913
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study.
Zingaropoli MA, Pasculli P, Iannetta M, Perri V, Tartaglia M, Crisafulli SG, Merluzzo C, Baione V, Mazzochi L, Taglietti A, Pauri F, Frontoni M, Altieri M, Gaeta A, Antonelli G, Conte A, Mastroianni CM, Ciardi MR. Zingaropoli MA, et al. Among authors: crisafulli sg. Mult Scler J Exp Transl Clin. 2022 Jan 4;8(1):20552173211065731. doi: 10.1177/20552173211065731. eCollection 2022 Jan-Mar. Mult Scler J Exp Transl Clin. 2022. PMID: 35003758 Free PMC article.
Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy.
Giossi R, Consonni A, Torri Clerici V, Zito A, Rigoni E, Antozzi C, Brambilla L, Crisafulli SG, Bellino A, Frangiamore R, Bonanno S, Vanoli F, Ciusani E, Corsini E, Andreetta F, Baggi F, Tramacere I, Mantegazza R, Conte A, Bergamaschi R, Confalonieri P. Giossi R, et al. Among authors: crisafulli sg. Mult Scler Relat Disord. 2022 Feb;58:103415. doi: 10.1016/j.msard.2021.103415. Epub 2021 Nov 22. Mult Scler Relat Disord. 2022. PMID: 35216790 Free PMC article.
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study.
Bisecco A, Fornasiero A, Bianco A, Cortese A, D'Amico E, Mataluni G, Sinisi L, Spitaleri D, Docimo R, Buscarinu MC, Mirabella M, Crisafulli SG, Zanghì A, Nicoletti CG, Salvetti M, Baione V, Patti F, Marfia AG, Sibilia G, Scarano V, Orlando D, Stabile G, Tedeschi G, Gallo A. Bisecco A, et al. Among authors: crisafulli sg. J Neurol. 2022 May;269(5):2824-2825. doi: 10.1007/s00415-022-11083-1. J Neurol. 2022. PMID: 35344079 Free PMC article. No abstract available.
15 results